Skip to main content
Clinical Trials/NCT06389903
NCT06389903
Completed
Not Applicable

Study of Symptoms Related to the Lesion Effect Associated With the Implantation of Electrodes for Stimulation of the Subthalamic Nuclei in the Treatment of Parkinson's Disease.

Centre Hospitalier du Rouvray1 site in 1 country15 target enrollmentJune 4, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Parkinson Disease
Sponsor
Centre Hospitalier du Rouvray
Enrollment
15
Locations
1
Primary Endpoint
Assessment of change of mania symptoms
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This is a pilot, prospective, monocentric study concerning 15 Parkinson's disease patients requiring deep brain stimulation implantation.

The primary objective is to evaluate the psychiatric lesion effects of deep brain stimulation in patients with Parkinson's disease, using the Young Mania Rating Scale (YMRS), Big Five Inventory and the Hamilton Depression Rating Scale (HAMD 21).

Detailed Description

The patients included were adults suffering from Parkinson's disease (according to ICD-10). They had no severe psychiatric disorders, and no major neurocognitive disorders contraindicating surgery. An initial evaluation will be carried out 72 hours after surgery, then after one month, and finally 3 months after surgery.

Registry
clinicaltrials.gov
Start Date
June 4, 2019
End Date
October 5, 2021
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Major patient
  • Diagnosis of Parkinson's disease (ICD-10)
  • L-dopa test must be positive
  • Participants who gave their informed, written consent

Exclusion Criteria

  • Severe psychiatric disorder
  • Major neurocognitive disorder contraindicating surgery

Outcomes

Primary Outcomes

Assessment of change of mania symptoms

Time Frame: Baseline, 72 hours, 1 month and 3 months after surgery

The variation of Young Mania Rating Scale (YMRS). The YMRS total score ranges from 0 to 60 where higher scores indicate more severe mania.

Secondary Outcomes

  • Assessment of confusion(72 hours and 3 months after surgery)
  • Assessment of change of depressive symptoms(Baseline, 72 hours, 1 month and 3 months after surgery)
  • Assessment of change of Impulsivity(Baseline, 72 hours, 1 month and 3 months after surgery)
  • Assessment of change of Behavior(Baseline, 72 hours, 1 month and 3 months after surgery)
  • Assessment of change of Apathy(Baseline, 72 hours, 1 month and 3 months after surgery)
  • Assessment of personality(Baseline)
  • Assessment of executive functions(Baseline, 72 hours, 3 months after surgery)

Study Sites (1)

Loading locations...

Similar Trials